Polyphenols as therapeutic molecules in Alzheimer's disease through modulating amyloid pathways
- PMID: 24826916
- DOI: 10.1007/s12035-014-8722-9
Polyphenols as therapeutic molecules in Alzheimer's disease through modulating amyloid pathways
Abstract
Alzheimer's disease (AD) is a complex and multifactorial neurodegenerative condition. The complex pathology of this disease includes oxidative stress, metal deposition, formation of aggregates of amyloid and tau, enhanced immune responses, and disturbances in cholinesterase. Drugs targeted toward reduction of amyloidal load have been discovered, but there is no effective pharmacological treatment for combating the disease so far. Natural products have become an important avenue for drug discovery research. Polyphenols are natural products that have been shown to be effective in the modulation of the type of neurodegenerative changes seen in AD, suggesting a possible therapeutic role. The present review focuses on the chemistry of polyphenols and their role in modulating amyloid precursor protein (APP) processing. We also provide new hypotheses on how these therapeutic molecules may modulate APP processing, prevent Aβ aggregation, and favor disruption of preformed fibrils. Finally, the role of polyphenols in modulating Alzheimer's pathology is discussed.
Similar articles
-
An Increasing Role of Polyphenols as Novel Therapeutics for Alzheimer's: A Review.Med Chem. 2020;16(8):1007-1021. doi: 10.2174/1573406415666191105154407. Med Chem. 2020. PMID: 31702507 Review.
-
Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.J Alzheimers Dis. 2021;82(s1):S335-S357. doi: 10.3233/JAD-200185. J Alzheimers Dis. 2021. PMID: 32568200 Free PMC article. Review.
-
Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.Int J Mol Sci. 2020 Oct 9;21(20):7443. doi: 10.3390/ijms21207443. Int J Mol Sci. 2020. PMID: 33050199 Free PMC article. Review.
-
Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer's Disease.Curr Neuropharmacol. 2023;21(4):787-807. doi: 10.2174/1570159X20666221010113812. Curr Neuropharmacol. 2023. PMID: 36221865 Free PMC article. Review.
-
Regulation of β cleavage of amyloid precursor protein.Neurosci Bull. 2010 Oct;26(5):417-27. doi: 10.1007/s12264-010-0515-1. Neurosci Bull. 2010. PMID: 20882069 Free PMC article. Review.
Cited by
-
Insights into the Neuroprotective Potential of Epicatechin: Effects against Aβ-Induced Toxicity in Caenorhabditis elegans.Antioxidants (Basel). 2024 Jan 8;13(1):79. doi: 10.3390/antiox13010079. Antioxidants (Basel). 2024. PMID: 38247503 Free PMC article.
-
The Influence of Gut Microbiota on Neurogenesis: Evidence and Hopes.Cells. 2022 Jan 23;11(3):382. doi: 10.3390/cells11030382. Cells. 2022. PMID: 35159192 Free PMC article. Review.
-
Polyamine Conjugation as a Promising Strategy To Target Amyloid Aggregation in the Framework of Alzheimer's Disease.ACS Med Chem Lett. 2016 Sep 26;7(12):1145-1150. doi: 10.1021/acsmedchemlett.6b00339. eCollection 2016 Dec 8. ACS Med Chem Lett. 2016. PMID: 27994754 Free PMC article.
-
Distinguishing the Effect on the Rate and Yield of Aβ42 Aggregation by Green Tea Polyphenol EGCG.ACS Omega. 2020 Aug 21;5(34):21497-21505. doi: 10.1021/acsomega.0c02063. eCollection 2020 Sep 1. ACS Omega. 2020. PMID: 32905372 Free PMC article.
-
α-Mangostin decreases β-amyloid peptides production via modulation of amyloidogenic pathway.CNS Neurosci Ther. 2017 Jun;23(6):526-534. doi: 10.1111/cns.12699. Epub 2017 Apr 21. CNS Neurosci Ther. 2017. PMID: 28429536 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical